Related by context. All words. (Click for frequent words.) 67 Maven Semantic 66 #:#-#,# CrossRef Medline [002] 66 See CLINICAL PHARMACOLOGY 66 Colin Baigent 66 Tuberculosis Vaccine 66 Renal Cancer 65 Initiates Phase III 65 Shows Promise Against 65 Initiates Phase 2b 65 Drug Shows Promise 65 Nicotine Vaccine 65 #-# Full Text 65 Cell Signalling 65 Inflammatory Arthritis 65 Vaccine Shows Promise 65 Reduces Mortality 65 Psoriasis Drug 65 Shows Efficacy 65 Gastrointestinal Oncology 65 Vaccine Immunology 64 Nicotine Addiction 64 Hematologic Malignancies 64 Prolongs Survival 64 #:#-#,# Medline 64 Cardiac Rhythm 64 Demonstrates Efficacy 64 Biostatistical 64 Rheumatoid Arthritis Drug 64 Successfully Completes Phase 64 Helps Smokers Quit 64 Inflammatory Diseases 64 Metabolic Disease 64 Romidepsin 64 Anticancer Drug 64 Combination REOLYSIN R 64 Schizophrenia Treatment 64 Initiate Clinical Trial 64 Demonstrates Sustained 64 Vaccine Protects Against 64 Current Controlled Trials 64 #:#-#,# CrossRef Medline [001] 64 NICE Recommends 64 pharmacogenomic translational research 64 ANN INTERN MED 64 Investigational Treatment 64 Clinical Guideline 63 Postdoctoral Position 63 Biomarker Study 63 Immunotherapeutic 63 Initiates Clinical Trial 63 Investigational Drug 63 Seasonal Influenza Vaccine 63 Severe Asthma 63 Gastric Cancer 63 Pediatric Oncology Branch 63 Treatment Shows Promise 63 Treatment Naive Patients 63 Novel Vaccine 63 Improve Diagnosis 63 Sleep Disturbances 63 Diagnostic Tests 63 Completes Patient Enrollment 63 HCV Protease Inhibitor 63 Therapeutic Antibody 63 Clinical Trials Unit 63 Clinical Trials Consortium 63 Confirms Efficacy 63 Clinical Evaluation 63 Tumor Microenvironment 63 #:#-#,# [002] 63 Treating Prostate Cancer 63 Submits NDA 63 Initiate Phase III 63 Molecular Epidemiology 63 Clinical Trial Enrollment 63 FDA Okays 62 Phase 2b Clinical Trial 62 Fondaparinux 62 Drug Fails 62 Novel Therapeutic 62 Lung Cancer Drug 62 Neurodegenerative Disorders 62 Cytometry 62 HER2 Positive 62 Treat Parkinson Disease 62 Drug Prevents 62 number NCT# ClinicalTrials.gov 62 Molecular Basis 62 Arch Neurol 62 Personalised Medicine 62 Genetic Disorders 62 Initiates Phase II 62 Vaccine Adjuvant 62 Diabetic Foot Ulcer 62 Neurodegenerative 62 Transdermal Delivery 62 Recurrent Breast Cancer 62 Brain Stimulation 62 Phase 2a Trial 62 #:#-#,# [003] 62 Therapy Shows Promise 62 Slows Progression 62 assn.org 62 Adverse Event 62 Improves Outcomes 62 Refractory Angina 62 #:#-#,# [001] 62 Investigational Compound 62 Initiates Enrollment 62 Clinical Neurology 62 Cognitive Problems 62 Protease Inhibitor 62 Male Contraceptive 62 Small Molecule 61 Receives Orphan Drug Designation 61 Blood Pressure Drug 61 Long Term Efficacy 61 Lowers Risk 61 Neurodevelopment 61 Laryngeal Cancer 61 Oral Insulin Capsule 61 Phase IIb Clinical Trial 61 Advanced Melanoma 61 Slow Progression 61 Oral Calcitonin 61 Therapeutic Vaccine 61 Autoimmune Disease 61 Disease Modifying 61 RNAi Therapeutic 61 NABTT 61 Bone Marrow Transplants 61 Cellular Immunology 61 Treating Depression 61 Initiates Clinical 61 Therapeutic Efficacy 61 BiTE Antibody 61 #:#-#,# CrossRef 61 Plaque Psoriasis 61 Drug Combo 61 Am J Geriatr 61 MassGeneral Institute 61 Protein Expression 61 Fabry Disease 61 Combination Treatment 61 Oral Fingolimod 61 Hematological Malignancies 61 Hsp# Inhibitor 61 Cardiovascular Magnetic Resonance 61 Neuromuscular Disorders 61 Immune Cell 61 MRC Clinical Trials 61 Clinical Outcome 61 Estrogen Therapy 61 Myelodysplastic Syndromes 61 Musculoskeletal Disorders 61 Rotavirus Vaccine 61 Carotid Stenting 61 Transdermal Patch 61 Clinical Pharmacy 61 Patients Receiving 61 Demonstrates Positive 61 Systemic Sclerosis 61 Files IND 61 Inflammatory Disease 61 Pregnancy Outcomes 61 Osteoporosis Drug 61 Severe Sepsis 61 Preclinical Models 61 Pancreas Cancer 61 Tyrosine Kinase Inhibitor 61 Genes Linked 61 Prostate Cancer Vaccine 61 Asthma COPD 61 Delcath Phase III 61 Protein Linked 61 Blood Thinner 61 HER2 Positive Breast Cancer 61 Clinical Outcomes 61 LSE ASM 61 Significantly Improves 61 Commercialize Novel 61 Diagnostic Criteria 61 Proves Effective 61 Schizophrenia Drug 60 Phase III Pivotal 60 Preterm Labor 60 Cellular Therapies 60 TNFerade TM 60 Antipsychotic Drug 60 Clinical Decision Making 60 Early Diagnosis 60 pioglitazone hydrochloride 60 Aflibercept 60 Accessed #/#/# [001] 60 Genes Identified 60 Glatiramer Acetate 60 Autoimmune Diseases 60 Suicidality 60 Cardiac Stem Cell 60 Prostate Disease 60 Molecular Virology 60 FDA Accepts 60 Intravenous Formulation 60 Crit Rev 60 Analytical Tool 60 orally inhaled migraine 60 Cancer Incidence Mortality 60 Test Detects 60 Magnetic Stimulation 60 Treated Patients 60 Desvenlafaxine 60 Antigen Specific 60 Treat Heart Failure 60 Coronary Revascularization 60 Chemotherapeutic Agents 60 Immunosuppressant 60 Statin Drugs 60 Breast Cancer Recurrence 60 RNAi Therapeutics 60 Prospective Randomized 60 Phase III multicenter 60 Chemoprevention 60 Behavioral Neurobiology 60 Preclinical Study 60 Novel Oral 60 Phase III Clinical Trial 60 Molecular Cancer 60 Novel Therapies 60 Demonstrates Significant 60 Clinical Trial Data 60 Guidelines Issued 60 Multiple Myeloma Patients 60 HAYS Agricultural 60 Neurodegenerative Disease 60 #:#-# [024] 60 GW# [003] 60 Pandemic Influenza Vaccines 60 Cholesterol Drug 60 Investigator Initiated 60 Patient Enrollment 60 Patients Treated With 60 Genetic Variation 60 Treating Chronic 60 Image Guided 60 Anticoagulation 60 Adenoma 60 Therapy Improves 60 TB Vaccine 60 Lupus Nephritis 60 Anti Nausea 60 Immunomedics Announces 60 Cardiometabolic 60 Diamyd Medical Diamyd 60 Develop Novel 60 Aggressive Reduction 60 SUTENT ® 60 Pulmonary Arterial Hypertension 60 Receives Complete Response 60 Neurological Diseases 60 Improved Survival 60 Cancer Immunotherapy 60 Renal Cell Cancer 60 Ocular Inflammation 60 Arthritis Drug 60 Prolongs Life 60 Cardiotoxicity 60 Paediatric Allergy 60 Hepatitis C Treatment 60 Venous Thromboembolism 60 Renal Transplantation 60 J Nutr 60 Respiratory Virus 60 Retrovirus 60 Tibotec BVBA 60 Inhaled Nitric Oxide 60 Arthritis Musculoskeletal 60 Study Demonstrates 60 Protein Interactions 60 Symptom Management 60 BioSante Pharmaceuticals Announces 60 Psycho Oncology 60 Acute Pain 60 Nutritional Metabolism 60 Begins Dosing 60 Dose Escalation 60 Study Evaluating 60 Vaccine Trials 60 Breast Tumor 60 Meets Primary Endpoint 60 Osteoporosis Treatment 60 Medication Adherence 60 Novel Antibiotic 60 Cardiovascular Outcomes 60 Hematological 60 Molecular Carcinogenesis 60 Onyx Pharmaceuticals Announces 59 Drug Approvals 59 Prostate Cancer Patients 59 Pluripotent Stem Cells 59 Extracellular Matrix 59 Clin J 59 Cancer Stem Cells 59 Bayer HealthCare Onyx Pharmaceuticals 59 Therapeutic Antibodies 59 Acute Heart Failure 59 Evaluative Sciences 59 Therapy Evaluation 59 Transplant Rejection 59 Genitourinary 59 Bipolar Disorders 59 TGen Clinical Research 59 Receives Positive Opinion 59 entitled Formulary Advantages 59 Heart Failure Patients 59 Investigational Agent 59 Clinical Psychopharmacology 59 Synthetic Peptide 59 Skin Lesions 59 Virus Linked 59 BrainGate TM 59 Stem Cell Transplant 59 Study Raises Questions 59 Anti Angiogenesis 59 Phase III Trial 59 Solid Tumor 59 Gastrointestinal Disorders 59 Licenses Novel 59 Pharmacogenetics 59 Inflammatory Markers 59 CNS Disorders 59 Acute Stroke 59 DAPT Study 59 PhD Studentships 59 Randomized Study 59 Antibody Drug Conjugate 59 Clinical Trial Results 59 Novel Mechanism 59 Multicentre 59 Breast Cancer Treatment 59 Ebola Vaccine 59 Neurochemistry 59 Therapeutic Vaccines 59 Subgroup Analysis 59 Oncologic 59 Fingolimod 59 Pharmacoepidemiology 59 Trodusquemine MSI 59 ASCO GI 59 Pivotal Phase III 59 Announce Collaboration Agreement 59 Stem Cell Transplants 59 Vasomotor Symptoms 59 Genes Predict 59 Improves Survival 59 Aethlon Medical Announces 59 Drug Maker 59 Cervical Dysplasia 59 Metabolic Disorder 59 National Perinatal Epidemiology 59 Therapeutic Agents 59 Cell Differentiation 59 Epilepsy Drug 59 Novel Therapeutics 59 Heart Transplant Recipients 59 Vaccine Adjuvants 59 Physiology Seminar 59 #:#-# [001] 59 Granted Orphan Drug 59 Cognitive Disorders 59 Hormone Refractory Prostate Cancer 59 Endocrinol 59 Treatment Reduces 59 Vulnerable Plaque 59 Protein Involved 59 Reports Preclinical Data 59 Infectious Disease Testing 59 Acute Treatment 59 Anemia Drug 59 Max Delbrueck Center 59 FDA Approves Drug 59 Submits Supplemental 59 developer Antisoma plc 59 Toxicogenomics 59 Brain Disorders 59 pralatrexate injection folate analogue 59 Randomized Phase II 59 Hedgehog Pathway Inhibitor 59 Anticancer Activity 59 Mg Usa 59 Companion Diagnostic 59 Acne Drug 59 Neuroepidemiology 59 Molecular Diagnostic Test 59 Presents Positive 59 Tumor Response 59 Erythropoiesis Stimulating Agents ESAs 59 Adjuvant Chemotherapy 59 Sipuleucel T 59 Drug Candidate 59 Multicenter Phase 59 Hematological Cancers 59 #:#-# [023] 59 Meta Analysis 59 Teva Provides Update 59 BRIM3 59 Translational Biology 59 Wellstat 59 Anti Infective 59 Pooled Analysis 59 Mimetics 59 Pathogen Detection 59 Anticancer Agents 59 Eases Pain 59 Childhood Fetal 59 MEK Inhibitor 59 Pharmacogenomic 59 Therapeutic Targets 59 Neuropharmacology 59 Lupus Drug 59 Obstet Gynecol 59 Smallpox Vaccine 59 Presents Preclinical Data 59 Complicated Skin 59 Observational Study 59 Submits Response 59 Metabolic Disorders 59 INSPIRE Trial Phase III 59 Psychosocial Oncology 59 Molecular Oncology 59 Cell Transplants 59 Improve Patient 59 Children Brain Tumour 59 Molecular Genetic 59 Presents Positive Preclinical 59 Oral Insulin 59 Biobehavioral 59 Companion Diagnostics 59 Nonclinical 59 Phase IIa Clinical Trial 59 Developmental Origins 59 DIRECT Trial 58 Phase 2b Study 58 Avian Flu Vaccine 58 Clinical Neuropsychology 58 Cytogenetics 58 Submits IND 58 Fibromyalgia Syndrome 58 Anti Clotting Drug 58 Helps Diagnose 58 Randomized Controlled 58 Multiple Ascending Dose 58 Demonstrates Potent 58 Islet Transplantation 58 Influenza Vaccine Production 58 Study Validates 58 Rheumatoid Arthritis Patients 58 Submits Biologics License Application 58 Hepatitis C Virus 58 Clinically Significant 58 Research www. elsevier.com 58 Progressive Multifocal Leukoencephalopathy 58 Clinical Neurosciences 58 Cholesterol Lowering Drug 58 Randomized Controlled Trials 58 Diagnosis Treatment 58 Treatment Approaches 58 Dose Ranging 58 Reperfusion Injury 58 Shows Promising 58 Pediatric Rheumatology 58 Molecular Biomarkers 58 Boxed Warnings 58 Prospective Multicenter 58 Hormone Therapy 58 Phase 2b RESTORE CLI 58 Genetic Predisposition 58 Bipolar Depression 58 Genes Discovered 58 Expanded Indication 58 Chronic Heart Failure 58 Diabetic Neuropathy 58 Gets FDA Clearance 58 Translational Oncology 58 Develops Novel 58 Antiviral Drugs 58 Systemic Delivery 58 Antidepressant Drug 58 Anticancer Agent 58 Integrase Inhibitor 58 Safe Medication 58 Urogenital 58 Advanced Heart Failure 58 Osteoarthritis Patients 58 Biological Therapy 58 Renal Impairment 58 Appears Safe 58 Clinical Practice Guideline 58 WHO TDR 58 Tissue Engineered 58 Lung Injury 58 IIa Clinical Trial 58 Therapeutic Potential 58 Stem Cell Treatment 58 Kidney Transplant Patients 58 Hepatitis B Vaccine 58 Treatment Resistant 58 Substance Dependence 58 Biorepository 58 Collaborators Present 58 Randomized Double Blind 58 ISTODAX ® 58 Therapeutic Advances 58 Phase 2b Trial 58 Molecular Pathogenesis 58 Genetic Marker 58 C1 Inhibitor 58 Immunologic 58 DNA Methylation 58 Arterial Disease 58 Emerging Therapies 58 M.D. Ph.D. 58 Cardiovascular Epidemiology 58 Overactive Bladder 58 NIHR Biomedical Research 58 Clinical Validation 58 Mouse Models 58 Inhaled Insulin 58 Nahum Sonenberg 58 NCIC CTG 58 ASM Biodefense 58 Unstable Angina 58 hyaluronidase enzyme 58 Preclinical Data 58 Reduced Risk 58 Atomoxetine 58 Mouse Model 58 Kinase Inhibitor 58 Randomized Clinical Trials 58 Therapeutic Intervention 58 Patients Suffering 58 Gene Mutation Linked 58 Intensive Care Medicine 58 #:#-# [007] 58 Late Breaker 58 Metabolomics 58 #:#-# [006] 58 CALGB 58 Beta Cell Biology 58 Eur J 58 Nanoemulsion 58 Initiate Phase II 58 Clinical Trial Evaluating 58 Phase Ib Clinical Trial 58 Drug Interaction 58 Clinical Trial 58 Pathology Informatics 58 Mutagenesis 58 Reproductive Genetics 58 Cardiovasc 58 Lipid Metabolism 58 Research Institute OHRI 58 Motility 58 NGFN 58 Therapeutic Competitors Report 58 Receives Milestone Payment 58 Study Shows Significant 58 FDA Approves Generic 58 Chicago Multidisciplinary Symposium 58 Phase Ib II 58 Migraine Treatment 58 Phase IIb Trial 58 Anthrax Toxin 58 Author Affiliation Department 58 Data Suggest 58 Prostate Biopsy 58 Immunotherapeutics 58 Drug Formulation 58 Hepatocellular Carcinoma 58 Perinatal HIV 58 Patient Oriented 58 Therapy Reduces 58 Epilepsy Surgery 58 Statistical Genetics 58 Pemphigus 58 Investigational Drugs 58 Vicriviroc 58 Receives Approvable Letter 58 Mitochondrial Medicine 58 Naive Patients 58 BiTE R 58 Stronger Warnings 58 Vertebral Fractures 58 Invasive Fungal Infections 58 Cholesterol Levels SPARCL 58 HCV SPRINT 58 ICAAC IDSA 58 Metabolic Diseases 58 Prenatal Diagnosis 58 Biochemical Pharmacology 58 Nurse Specialist 58 #:#-# [032] 58 Biomarker Discovery 58 Teresa Graedon Ph.D. 58 Hedgehog Pathway 58 Neuroendocrine Tumors 58 Replacement Therapy 58 Genetic Diseases 58 ICON7 58 Childhood Trauma 58 Oncolytic 58 Artificial Pancreas 58 Osteoarthritis Pain 58 Hepatocellular 58 Predictive Toxicology 58 Phase 1b Clinical Trial 58 Regenerative Cell 58 Mitral Valve Repair 58 Clinical Proteomics 58 Study Shows Promise 58 Urologic Cancer 58 Monoclonal Antibody 58 www.ecri.org 58 Musculoskeletal Diseases 58 Bone Metastases 58 Clinician Scientist 58 Vasc 58 Pediatric Psychopharmacology 58 adalimumab Humira 58 Therapeutic Approaches 58 Cell Signaling 58 Brain Tumors 58 Whole Genome Sequencing 58 Childhood Asthma 58 Clinical Neurophysiology 58 GENASIS 58 Helps Predict 58 Generalized Anxiety Disorder 58 Multidrug Resistant 58 Gene Linked 58 Randomized Evaluation 58 Kinase Inhibitors 58 Liver Toxicity 58 Pharmacoeconomic 58 Aryplase 58 Neurotherapeutics 58 Low Incidence 58 Ovarian Cancer Patients 58 Immune Therapy 58 Genetic Makeup 58 Lung Cancers 58 #:#-# [035] 58 ST Segment Elevation 58 RhuDex 58 Biologic Therapy 58 NCI Cancer 58 Stroke Prevention 58 Developmental Genetics 58 H#N# Influenza Vaccine 58 Subtypes 58 First Patient Treated 57 CELVAPAN H#N# 57 Combo Therapy 57 Lymphoma Patients 57 #:#-# [031] 57 Enlarged Prostate 57 Study Sheds Light 57 Lowering Blood Pressure 57 Lung Cancer Patients 57 FOLOTYN ® 57 Tissue Repair 57 Scientific Abstracts 57 SANDY MILLER 57 Female Urology 57 Brentuximab Vedotin SGN 57 Battelle Biomedical 57 Protein Synthesis 57 Announces FDA Clearance 57 JAK Inhibitor 57 Largest Database 57 Pandemic Influenza Vaccine 57 Antiarrhythmic 57 Circulatory Support 57 Individualized Therapy 57 Epilepsy Drugs 57 Male Infertility 57 Receives CE Marking 57 Pegloticase 57 Renal Cell Carcinoma 57 Novel Treatments 57 Hospital Acquired Pneumonia 57 Vitrasert R 57 Atypical Antipsychotic 57 Nuclear Receptors 57 Human Retroviruses 57 Acute Decompensated Heart Failure 57 Novel Inhibitor 57 Gout Drug 57 Bioimaging 57 Shows Statistically Significant 57 LibiGel ® 57 Antibody Therapeutics 57 Systematic Review 57 Protein Biomarker 57 Bosutinib 57 Adjuvant Treatment 57 Gastrointestinal Cancers 57 Hormonal Contraceptives 57 Receives Fast Track 57 Institute DCRI 57 Diet Linked 57 Cardiovascular Interventional 57 psoriasis inflammatory bowel 57 Shingles Vaccine 57 Experimental Therapeutics Program 57 Investigational Oral 57 including eniluracil ADH 57 PhD MGH 57 R lenalidomide 57 Receives Orphan Drug 57 visit www.health.state.pa.us 57 Clinical Physiology 57 Bone Marrow Transplantation 57 Initiates Dosing 57 Arch Pediatr Adolesc Med 57 Gene Silencing 57 Implantable Device 57 Post Menopausal 57 Chronic Hepatitis B 57 Pharmacologic 57 VIVUS Announces 57 Safinamide 57 Guidelines Recommend 57 Genetic Disease 57 Allergic Diseases 57 Non Invasive Treatment 57 Desvenlafaxine Succinate 57 Mammography Screening 57 Valvular Heart Disease 57 Prevent Stroke 57 Prostate Cancer Treatment 57 Showed Significant 57 Services #:#-#,# Abstract 57 Anti Virals 57 Oxidative Stress 57 Files Investigational 57 Muscle Wasting 57 Sustained Efficacy 57 Tumor Angiogenesis 57 Psychiatry #:#-# [002] 57 Partnering Agreements 57 Cardiac Resynchronization 57 Neuroanatomy 57 Arthritis Drugs 57 Lymphoid 57 Ann Emerg Med 57 Sapacitabine 57 Prognostic Value 57 Generic Versions 57 Radiopharmaceutical 57 Hepatic Encephalopathy 57 Inhaled Liposomal Ciprofloxacin 57 Peer Reviewed Medical 57 please visit www.metabolon.com 57 Clinical Translational 57 Infected Patients 57 Vaccine Candidate 57 Genitourinary Medicine 57 ASGCT 57 Genetic Markers 57 Atopic Dermatitis 57 Mitchell Krucoff 57 Migraine Drug 57 ARIXTRA R 57 Temsirolimus 57 Hospitals NHS Trusts 57 J Clin Endocrinol Metab 57 Predict Risk 57 Cancer Vaccines 57 Protease Inhibitors 57 Proellex TM 57 J Am Coll 57 Breast Cancer Metastasis 57 Aurora Kinase 57 Lankenau Institute 57 Less Invasive 57 Pharmacogenetic 57 Neuroprotection 57 Clinical Neuroscience 57 Epidemiological Studies 57 Integrative Neuroscience 57 Immunotherapies 57 Postmarketing 57 Efficacy Trial 57 Professor Valerie Beral 57 Benign Prostatic Hyperplasia 57 Researchers Identify 57 Product Monograph 57 Community Acquired Pneumonia 57 Clostridium difficile Infection 57 Mylan Receives Approval 57 Neoadjuvant Chemotherapy 57 Protein Structure 57 forodesine 57 Liprotamase 57 Interferon Alpha 57 Professor Kaye Wellings 57 Often Misdiagnosed 57 J Clin 57 Clinical Therapeutics 57 Genes Involved 57 HORIZONS AMI 57 Urinary Incontinence 57 Nat Rev 57 Psychologist Clinical 57 FDA CDER 57 STRIDE PD 57 Molecular Evolution 57 Reduces Pain 57 Novel Small Molecule 57 Patient Recruitment 57 Estrogen Receptor 57 Cellular Tissue 57 Metabolic Bone Disease 57 Pertuzumab 57 Antiplatelet 57 Mesothelioma Treatment 57 midstage clinical 57 AVI BioPharma Announces 57 FRACP 57 Refractory Hodgkin Lymphoma 57 Orphan Diseases 57 Node Positive 57 Intervention Effectiveness 57 Microbial Identification 57 Neurotoxicity 57 Artificial Organs 57 Diabetes Interventions 57 Randomized Placebo controlled 57 Neil Scolding 57 Prenatal Screening 57 Insulin Sensitivity 57 JAK2 Inhibitor 57 Obese Teens 57 Autoimmune Disorders 57 PRIALT 57 Osteoporosis Drugs 57 Lung Cancer Survival 57 Breast Carcinoma 57 Orthomolecular Medicine 57 Postmenopausal Osteoporosis 57 Mycophenolate Mofetil 57 Renal Artery 57 Romiplostim 57 Hypertensive Patients 57 PROTECT AF 57 Glufosfamide 57 Cardiac Arrhythmia 57 Applied Polymer 57 Diabetic Nephropathy 57 Genetic Counseling 57 Viral Infections 57 Phase III AFFIRM 57 Surgical Treatment 57 Peginterferon alfa 2b 57 Treatment Naïve 57 Antibody Discovery 57 Clinical Practice Guidelines 57 Significantly Improved 57 Roche MabThera 57 Entereg TM 57 Antipsychotic Medications 57 Is Well Tolerated 57 Wound Repair 57 Pediatric Pharmacology 57 FDA Approvals 57 Radiation Induced 57 Psychiatric Epidemiology 57 Synaptic Plasticity 57 Antiepileptic Drug 57 MAGE A3 ASCI 57 Diabetes Complications 57 FDA Clears 57 Vascular Disrupting Agent 57 Proven Effective 57 Survival Benefit 57 Pharmacoeconomics 57 Carotid Endarterectomy 57 Synergyst 57 Differential Diagnosis 57 IND Filing 57 Pivotal Trials 57 Newly Diagnosed Breast Cancer 57 Ph.D. D.Sc. 57 Limb Ischemia 57 PRN FDA Approves 57 Cardiac Imaging 57 Spinal Manipulation 57 VIVITROL ® 57 Blood Cancers 57 Chronic Lymphocytic Leukemia CLL 57 Clinical Trial Investigating REOLYSIN 57 Tesmilifene 57 Oral Laquinimod 57 Biochemical Genetics 57 Microbicide Development 57 Developmental Therapeutics 57 Scripps Genomic Medicine 57 Pharmaceuticals Initiates 57 J Pediatr 57 Deforolimus 57 ASCO GU 57 Poster Presentations 57 Digital Pathology 57 Phase Ib IIa 57 Molecular Diagnostic 57 Lung Cancer Trial 57 Fungal Infections 57 Targeted Therapy 57 Newly Diagnosed 57 Completes Enrollment 57 Kidney Transplantation 57 Sexual Dysfunction 57 Diastolic Heart Failure 57 Insulin Resistance 57 Cutaneous T 57 Inherited Disease Research 57 Sequencing Systems 56 Atherosclerosis Research 56 Metabolic Bone Diseases 56 Cancer Immunology Immunotherapy 56 Lung Biology 56 Germ Cell 56 Sangamo BioSciences Announces 56 Stent Placement 56 Combunox 56 Hormone Replacement 56 Humanized Anti 56 Renal Cell Carcinoma RCC 56 Recombinant Protein 56 GATTEX TM 56 Nutrition Metabolism 56 Hematopoietic Stem Cell Transplantation 56 Exploratory Clinical 56 Bucindolol 56 Enzyme Replacement Therapy 56 Present Preclinical Data 56 Evaluation Program CTEP 56 REMINDER ORLive Presents 56 ProfNet Wire Health 56 Julia Hippisley Cox 56 CYP#A# substrate 56 Awarded Qualifying Therapeutic 56 Paliperidone Palmitate 56 Luigi Ferrucci 56 Begins Clinical Trial 56 Gynecologic 56 Antiangiogenic 56 General Psychiatry #:#-#,# 56 Uterine Fibroid 56 Molecular Mechanism 56 Recurrent Glioblastoma 56 Thurston Arthritis 56 Septic Shock 56 Adjunctive Therapy 56 Therapeutic Competitors Companies 56 Study Casts Doubt 56 Carbidopa Levodopa 56 Menopausal Symptoms 56 http:/www.clinicaltrials.gov 56 AFREZZA TM 56 Tyrosine Kinase Inhibitors 56 Smoking Cessation 56 Cardiovascular Disease Risk 56 Commences Phase III 56 Hematology Molecular Pathology 56 See WARNINGS 56 Edward Giovannucci 56 Antitumor Activity 56 Phase IIb III 56 Contrast Enhanced 56 Prostate Cancers 56 J Neurosurg 56 Male Fertility 56 Medtronic CoreValve ® 56 Discoveries Tomorrow 56 Monoclonal antibody 56 Translational Science Award 56 Cancer Epidemiology Unit 56 Left Ventricular Hypertrophy 56 Am J Epidemiol 56 different sweetener saccharin 56 theAmerican Journal 56 Stomach Cancer 56 Erythropoietic 56 Clinical Decision 56 Metastatic Melanoma 56 Effectively Treats 56 Phase 2a Clinical Trial 56 Vaginal Infections